Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Plos Neglected Tropical Diseases
|
May 3, 2018
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
Ari Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos Neglected Tropical Diseases
|
June 16, 2017
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
Ari Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Influenza and Other Respiratory Viruses
|
June 10, 2026
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity Study
Lena Pracher, Mastura Wahedi, Anselm Jorda, et al.
Plos Neglected Tropical Diseases
|
August 18, 2016
Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial
Joshua Nealon, Anne-Frieda Taurel, Maria Rosario Capeding, et al.
Influenza and Other Respiratory Viruses
|
November 21, 2024
Influenza in Adults Seeking Care at Seven European Emergency Departments: A Prospective Active Surveillance During the 2019-2020 Influenza Season
Sélilah Amour, Alberto Perez Rubio, Andrea Orsi, et al.
Plos Neglected Tropical Diseases
|
February 24, 2023
Age distribution of dengue cases in southern Vietnam from 2000 to 2015
Anne-Frieda Taurel, Chan Quang Luong, Thi Thanh Thao Nguyen, et al.
Pilot and Feasibility Studies
|
April 22, 2022
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
Niklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Respiratory Investigation
|
November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial
Lisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
Human Vaccines & Immunotherapeutics
|
January 8, 2026
A Bayesian re-analysis of the DANFLU-1 trial
Daniel Modin, Niklas Dyrby Johansen, Anders Granholm, et al.
Circulation. Cardiovascular Quality and Outcomes
|
August 31, 2024
Relative Effectiveness of High-Dose Versus Standard-Dose Quadrivalent Influenza Vaccine in Older Adults With Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical Trial
Jacob Christensen, Niklas Dyrby Johansen, Daniel Modin, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Plos Neglected Tropical Diseases
|
May 3, 2018
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
Ari Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos Neglected Tropical Diseases
|
June 16, 2017
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
Ari Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Influenza and Other Respiratory Viruses
|
June 10, 2026
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity Study
Lena Pracher, Mastura Wahedi, Anselm Jorda, et al.
Plos Neglected Tropical Diseases
|
August 18, 2016
Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial
Joshua Nealon, Anne-Frieda Taurel, Maria Rosario Capeding, et al.
Influenza and Other Respiratory Viruses
|
November 21, 2024
Influenza in Adults Seeking Care at Seven European Emergency Departments: A Prospective Active Surveillance During the 2019-2020 Influenza Season
Sélilah Amour, Alberto Perez Rubio, Andrea Orsi, et al.
Plos Neglected Tropical Diseases
|
February 24, 2023
Age distribution of dengue cases in southern Vietnam from 2000 to 2015
Anne-Frieda Taurel, Chan Quang Luong, Thi Thanh Thao Nguyen, et al.
Pilot and Feasibility Studies
|
April 22, 2022
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
Niklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Respiratory Investigation
|
November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial
Lisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
Human Vaccines & Immunotherapeutics
|
January 8, 2026
A Bayesian re-analysis of the DANFLU-1 trial
Daniel Modin, Niklas Dyrby Johansen, Anders Granholm, et al.
Circulation. Cardiovascular Quality and Outcomes
|
August 31, 2024
Relative Effectiveness of High-Dose Versus Standard-Dose Quadrivalent Influenza Vaccine in Older Adults With Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical Trial
Jacob Christensen, Niklas Dyrby Johansen, Daniel Modin, et al.
Page
of 8